Journal
EXPERT REVIEW OF PROTEOMICS
Volume 13, Issue 4, Pages 435-445Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14789450.2016.1159960
Keywords
Epigenetics; histone acetylation; high-throughput sequencing; chromatin modifications; HDAC inhibitors
Categories
Ask authors/readers for more resources
Many epigenetic-based therapeutics, including drugs such as histone deacetylase inhibitors, are now used in the clinic or are undergoing advanced clinical trials. The study of chromatin-modifying proteins has benefited from the rapid advances in high-throughput sequencing methods, the organized efforts of major consortiums and by individual groups to profile human epigenomes in diverse tissues and cell types. However, while such initiatives have carefully characterized healthy human tissue, disease epigenomes and drug-epigenome interactions remain very poorly understood. Reviewed here is how high-throughput sequencing improves our understanding of chromatin regulator proteins and the potential implications for the study of human disease and drug development and discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available